FDA approves Camzyos for children with obstructive hypertrophic cardiomyopathySep 30Regulatory decisionmavacamten
BMS registers Phase 1 CAR T cell trial in kidney cancer; adds mavacamten real-world studySep 30Weekly roundup, 2 itemsBristol Myers SquibbmavacamtenUpdated
Bristol Myers Squibb raises 2026 guidance, cites pipeline progress across four programsJul 30Quarterly updateBristol Myers Squibbluspatercept
Sign inSign in